Volkswagen Auto Lease Trust 2026-C Capital Raise of $745M
Volkswagen Auto Lease Trust 2026-C filed a prospectus for the issuance of $745.15 million in aggregate principal amount of asset-backed notes across five classes (A-1 through A-4). The offering is backed by a pool of auto leases and related vehicles managed by VW Credit, Inc. as sponsor.
Volkswagen Auto Lease Trust 2026-C Capital Raise of $745M
Volkswagen Auto Lease Trust 2026-C entered into an underwriting agreement with TD Securities and other underwriters for the sale of $745.15 million in asset-backed notes across five classes (Class A-1 through A-4). The notes are backed by a special unit of beneficial interest in retail automobile leases and related Volkswagen and Audi vehicles, with the closing expected on November 18, 2026.
Audax Private Credit Fund, LLC completed a private placement of 1,697,178.962 common shares to accredited investors for total consideration of $42.2 million. The offering was priced at $24.86 per share, which matches the Fund's reported net asset value as of September 30, 2026.
AIRO Group Holdings entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. to establish an at-the-market (ATM) offering program. Under the agreement, the company may issue and sell shares of its common stock from time to time at its sole discretion. AIRO will pay the agent a commission of 3.0% of the gross sales proceeds from any shares sold under the program.
SHF Holdings entered into a waiver agreement with CREO Investments LLC to extend the deadline for filing an additional registration statement to November 13, 2026. The registration is required following a conversion price adjustment to the company's Series B Preferred Stock to $0.1210 per share. The waiver prevents the accrual of registration delay payments that would have otherwise been triggered by missing the original November 6 deadline.
Host Hotels & Resorts entered into a new distribution agreement to establish an at-the-market (ATM) equity offering program for up to $600 million of common stock. This agreement replaces a prior $600 million ATM program that was terminated concurrently with the new filing. The company intends to use any net proceeds for general corporate purposes, including potential acquisitions and debt repayment.
Aptevo Therapeutics entered into warrant inducement agreements resulting in the cash exercise of existing warrants for 2,777,778 shares at a reduced price of $1.08 per share. The company received $3.0 million in gross proceeds and issued new 'reload' warrants for up to 13,888,890 additional shares to the participating holders. Proceeds will be used for working capital and general corporate purposes.
OptimumBank Holdings closed a private placement offering of 1,290,322 shares of common stock to an institutional accredited investor at $7.75 per share. The transaction resulted in gross proceeds of approximately $10 million and was conducted as an unregistered sale of equity securities.
BHAV Acquisition Corp II announced the partial exercise of the underwriters' over-allotment option, resulting in the sale of 509,855 additional units for gross proceeds of approximately $5.1 million. Simultaneously, the company's sponsor, BHAV Partners II LLC, purchased an additional 5,098 private units for $50,980 to maintain trust account requirements.
Hometown Financial Group entered into an agency agreement with Keefe, Bruyette & Woods (KBW) to act as the exclusive marketing agent for its common stock offering. The offering is part of a mutual-to-stock conversion, with the company offering between 51 million and 69 million shares (potentially up to 79.35 million) at a fixed price of $10.00 per share.
Live Oak Bancshares, Inc. closed an underwritten public offering of 4,000,000 depositary shares, each representing a 1/40th interest in its 8.750% Fixed Rate Series B Non-Cumulative Perpetual Preferred Stock. The offering raised approximately $96.25 million in net proceeds after underwriting discounts and expenses, with the shares carrying a liquidation preference of $25 per depositary share.
SmartStop Self Storage REIT Capital Raise of $334M
SmartStop Self Storage REIT entered into forward sale agreements for an aggregate of 9,372,500 shares of common stock at an initial forward price of $35.6125 per share. The offering includes 8,150,000 initial shares and 1,222,500 shares from the full exercise of the underwriters' overallotment option. The company intends to use the net proceeds from the eventual settlement of these agreements to fund pending investments, including a Canadian joint venture and potential acquisitions.
PepGen Inc. entered into an underwriting agreement to sell 25,000,000 shares of common stock at a public offering price of $5.00 per share. The company expects to raise approximately $125.0 million in gross proceeds (excluding the underwriters' 30-day option for an additional 3.75 million shares) to fund clinical development and general corporate purposes.
Candel Therapeutics entered into a Second Amended and Restated Open Market Sale Agreement with Jefferies LLC to establish a new at-the-market (ATM) equity facility. The agreement allows the company to sell up to $50 million of common stock from time to time, in addition to the $50 million previously sold under a prior 2025 agreement.
Neuronetics, Inc. entered into an underwriting agreement to sell 18,750,000 shares of common stock at a public offering price of $1.60 per share. The company also granted underwriters a 30-day option to purchase an additional 2,812,500 shares, bringing the total potential gross proceeds to approximately $34.5 million. Net proceeds will be used to repay a portion of outstanding term loans under its Perceptive Credit Facility and for general corporate purposes.
WF Card Issuance Trust, an entity sponsored by Wells Fargo Bank, completed the issuance of its Class A(2026-2) Notes on November 12, 2026. In connection with the closing, the depositor reported a Transferor Interest of approximately $4.12 billion to satisfy U.S. credit risk retention requirements.
Honda Auto Receivables 2026-4 Owner Trust Capital Raise
Honda Auto Receivables 2026-4 Owner Trust completed the issuance and sale of Class A-1, A-2a, A-2b, A-3, and A-4 Asset Backed Notes. The transaction involved the transfer of retail installment sale contracts for Honda and Acura automobiles from American Honda Finance Corporation to the issuing entity through a series of definitive agreements including an Indenture and Sale and Servicing Agreement.
Stockholders of Daré Bioscience approved the potential future issuance of common stock upon the exercise of outstanding warrants in accordance with Nasdaq listing rules. The approval was obtained at a special meeting held on November 10, 2026, ensuring compliance with dilution limits for a previously initiated capital raise.
Boxlight stockholders approved several proposals at a special meeting, including the issuance of shares exceeding 19.99% of outstanding stock related to Series D and Series E Preferred Stock financings and an equity line of credit. These approvals satisfy Nasdaq Listing Rule 5635(d) and are part of the company's plan to maintain compliance with Nasdaq's stockholders' equity requirements. The company expects to receive $2 million from the second tranche of its Series D financing and begin utilizing a $15 million equity line of credit.
Neuronetics, Inc. entered into an underwriting agreement to sell 18,750,000 shares of common stock at $1.60 per share, with an additional 2,812,500 shares available via an underwriters' option. The company expects to raise approximately $30 million in gross proceeds ($27.7 million net) to repay debt under its Perceptive Credit Facility and for general corporate purposes.
GT Biopharma shareholders approved a significant increase in authorized common shares from 25 million to 250 million and authorized the issuance of more than 19.99% of outstanding stock. These approvals facilitate the conversion of Series M Preferred Stock and the exercise of warrants related to a Securities Purchase Agreement dated September 14, 2026. The vote ensures compliance with Nasdaq Rule 5635 regarding the potential dilution from these previously announced financing transactions.
Prime Medicine, Inc. entered into an underwriting agreement for a public offering of 35,714,286 shares of common stock at $3.50 per share. The company also granted underwriters a 30-day option to purchase up to an additional 5,357,142 shares, bringing the total potential gross proceeds to approximately $143.75 million. Proceeds will be used to advance the company's Wilson disease and alpha-1 antitrypsin deficiency programs and for general corporate purposes.
Southport Acquisition Corp. II announced that holders of units issued in its initial public offering may elect to separately trade the underlying Class A ordinary shares and warrants starting November 16, 2026. The separated securities will trade on the NYSE under the symbols 'PORT' and 'PORT WS', while unseparated units will continue to trade under 'PORT U'.
Addentax Group Corp. entered into a private placement agreement with investor Chan Kai Fung to sell 312,500 shares of common stock at $4.80 per share. The transaction is expected to generate gross proceeds of approximately $1.5 million for general corporate purposes and working capital.
Bluerock Acquisition Corp. II announced that holders of the 17,250,000 units sold in its initial public offering may elect to separately trade the underlying Class A ordinary shares and warrants starting November 16, 2026. The units were originally issued in an IPO completed on September 28, 2026, and will continue to trade under the symbol 'BRRKU' if not separated.
Aptera Motors Corp. entered into a securities purchase agreement for a $6 million registered direct offering and concurrent private placement. The company is selling 3,428,571 shares of Class B common stock at $1.75 per share along with warrants to purchase an equal number of shares. Proceeds will be used for general corporate purposes and manufacturing readiness for its solar mobility vehicles.
National Healthcare Properties, Inc. entered into an ATM Equity Offering Sales Agreement to establish an at-the-market offering program for up to $300.0 million of its common stock. The program includes provisions for forward sale agreements with various financial institutions acting as agents and forward purchasers. Proceeds are intended for general corporate purposes, which may include funding acquisitions or repaying debt under its existing credit facilities.
Live Oak Acquisition Corp. VI announced that holders of units issued in its initial public offering may elect to separately trade the underlying Class A ordinary shares and warrants starting November 13, 2026. The separated securities will trade on Nasdaq under the symbols 'LOVI' and 'LOVIW', while unseparated units will continue to trade under 'LOVIU'. This is a standard post-IPO administrative step for SPACs to facilitate independent trading of equity and warrants.
Forward Industries amended its at-the-market (ATM) equity offering program to add Barclays Capital Inc. as an additional sales agent alongside Cantor Fitzgerald. The program allows the company to sell up to $4 billion in common stock to fund its Solana (SOL) treasury strategy.
Origin Tea Inc. completed a private placement of 290,000 shares of common stock to 115 non-U.S. purchasers in reliance on Regulation S. The company raised a total of RMB 11,600,000 (approximately RMB 40.00 per share) and granted the purchasers contractual resale registration rights.